Author Archives: Mayur Kumar

Whether your organization has already begun the necessary process of incorporating data analytic and artificial intelligence into pharmacy operations or it is undergoing a due diligence project to decide if it’s time to implement a pharmacy technology upgrade initiative, one thing is for sure: Data analytic and artificial intelligence will have a tremendous impact on […]

As the economic implications of the pandemic redefine the parameters of payer decision-making, the need for agile strategic insight – and greater collaboration – has only intensified. Pharma finds itself at the brink of great change. But in a US market increasingly driven by extreme unknowns, one thing has become crystal clear: deep understanding of […]

Pharmaceutical is one of the biggest industries in the US. The industry is characterized by excessively high-profit margins, and profitability exceeding costs. These are also some of the richest companies in the world with most of them having production set ups in many other countries and having strong distribution channels that completely cover the globe. […]

Quantifying the total impact that COVID-19 has had on the pharmaceutical industry will take time and analysis. However, we do have early indications of how COVID-19 is impacting promoted vs. non- promoted in-line brands in market. Currently, the effects of COVID-19 are proving to be more severe for mature, in-line brands. Despite recent headwinds, these […]

Orphan drugs (ODs) for rare diseases (RDs) present pharma companies with the opportunity to address a substantial unmet medical need. There are approximately 7,000 RDs, and only about five percent have effective treatments. In the US, around 25-30 million people are affected by a RD; many are often chronic and deteriorating conditions, with the majority […]

Digital Transformations in the pharmaceutical industry offers a mechanism to revise its business model, to improve production processes, and to increase its responsiveness to customers. Furthermore, the volume of data processed by pharmaceutical firms shows no sign of slowing down. This means pharmaceutical companies must act quickly in terms of building core internal digital capabilities […]

Pharma labeling, Bringing a new drug to market takes significant investment. By the time it reaches manufacturing status, hundreds of millions of dollars will have been spent in the trial and development phases.   Once the drug enters the manufacturing process, meeting regulations and maintaining compliance adds more costs to bringing it to market. Therefore, […]

While most industries have suffered immense disruption during the COVID-19 pandemic, the life sciences industry has been under more pressure than most to sustain operations as usual. Maintaining normal lines of supply, and accelerating the delivery of new medicines and vaccines, have been paramount to protect lives. Yet restrictions to routine ways of working have […]

Artificial Intelligence has already proved itself as an effective tool to support the research carried out by pharmaceutical companies. However, as companies begin to invest heavily in the technology, they would be wise to explore the impact it could have commercially. In January, Paul Shawah, senior vice president of Veeva Commercial Cloud, backed Artificial Intelligence […]